Facility

At NovoBliss Research®, we operate from a state-of-the-art, purpose-built 12,000 sq. ft. facility in Ahmedabad, India, meticulously designed to meet the highest international standards for research, quality, and regulatory compliance. Our CDSCO-registered and ISO 9001:2015-certified infrastructure embodies our unwavering commitment to scientific excellence, ethical conduct, and operational precision. As a comprehensive Contract Research Organization (CRO), NovoBliss provides end-to-end research solutions across pharmaceuticals, dermatology, cosmetics, nutraceuticals, herbal and ayurvedic formulations, medical devices, and personal healthcare products, ensuring global partners receive credible, compliant, and cutting-edge research outcomes.

As a full-spectrum Contract Research Organization (CRO), NovoBliss delivers end-to-end research solutions across diverse sectors including pharmaceuticals, dermatology, cosmetics, nutraceuticals, herbal and ayurvedic formulations, medical devices, and personal healthcare products. Our integrated capabilities encompass preclinical (in-vitro and ex-vivo) studies, Phase I–IV clinical trials, real-world evidence research, safety assessments, and regulatory support, ensuring scientific excellence from concept to commercialization.

Technology and Infrastructure

Our infrastructure is equipped with state-of-the-art bio-instruments sourced from globally recognized brands such as Courage + Khazaka, Delfin, CASLite Nova, Testronix, and Image Pro Analysis Software, among others. Every key instrument is maintained in a paired configuration to provide seamless redundancy — ensuring uninterrupted operations, data reliability, and uncompromised precision in every study.

The facility features dedicated spaces for specialized teams including Biostatistics, Medical Writing, and Clinical Operations, purposefully designed to foster cross-functional collaboration, maintain data integrity, and enhance workflow efficiency. Supplementary areas such as seminar halls, collaborative lounges, and a secured document archiving zone reinforce our culture of continuous learning, compliance, and innovation.

Quality, Ethics, and Compliance

Every study conducted at NovoBliss Research® adheres to validated methodologies, stringent SOPs, and Good Clinical Practice (GCP) and ICMR guidelines. Our processes are built around transparency, reproducibility, and ethical responsibility, ensuring that each outcome we deliver stands up to the highest scientific and regulatory scrutiny.

At NovoBliss Research®, we are more than a facility — we are a precision-driven ecosystem where science, innovation, and integrity converge to advance the future of evidence-based research, globally.